Search Results

ColonCARE is a rapid, convenient, hygienic and highly sensitive (0.05 µg hHb/ml) method for the qualitative detection of occult blood in feces, which may be indicative of gastrointestinal diseases associated with bleeding such as colorectal carcinoma, Crohn's disease, ulcerative colitis, and colon polyp:

The test is recommended for use in the home or in medical facilities as a screening test for colorectal cance or gastrointestinal bleeding from any source.

Not Found

This document is a 510(k) clearance letter for the ColonCARE device, which means it does not contain the detailed study information required to answer your questions about acceptance criteria and device performance.

The FDA 510(k) clearance process primarily ensures that a new device is "substantially equivalent" to a legally marketed predicate device. While this process involves review of data demonstrating safety and efficacy, the specific details of performance studies, acceptance criteria, ground truth establishment, expert qualifications, and AI-specific metrics (like MRMC studies) are not typically included or summarized in the clearance letter itself. These details would be found in the original 510(k) submission document submitted by the manufacturer.

Therefore, I cannot provide the requested information based solely on the provided text.

To answer your questions, I would need to access the full 510(k) submission for ColonCARE (K030216), which is generally not publicly available in its entirety. Some summaries are available, but they rarely include the fine-grained detail you're requesting.

Ask a specific question about this device